Takao Shishido

Osaka, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications

In Vitro Selection and Characterization of Tecovirimat-resistant Mpox Virus.

In Vitro Selection and Characterization of Tecovirimat-resistant Mpox Virus.

Journal: The Journal of infectious diseases
Published: December 23, 2025

Evaluation of therapeutic efficacy of baloxavir marboxil against high pathogenicity avian influenza virus infection in duck model.

Evaluation of therapeutic efficacy of baloxavir marboxil against high pathogenicity avian influenza virus infection in duck model.

Journal: PloS one
Published: December 18, 2025

A cap-dependent endonuclease inhibitor acts as a potent antiviral agent against La Crosse virus infection.

A cap-dependent endonuclease inhibitor acts as a potent antiviral agent against La Crosse virus infection.

Journal: Antimicrobial agents and chemotherapy
Published: July 23, 2025

Assessment of a baloxavir marboxil treatment protocol for high pathogenicity avian influenza in Okinawa Rails, an endangered species endemic to Japan.

Assessment of a baloxavir marboxil treatment protocol for high pathogenicity avian influenza in Okinawa Rails, an endangered species endemic to Japan.

Journal: PloS one
Published: July 18, 2025

Synergistic antiviral activity of a cathepsin B/L inhibitor and a TMPRSS2 inhibitor against SARS-CoV-2 in vitro and in vivo.

Synergistic antiviral activity of a cathepsin B/L inhibitor and a TMPRSS2 inhibitor against SARS-CoV-2 in vitro and in vivo.

Journal: Virology
Published: May 22, 2025

Ensitrelvir treatment-emergent amino acid substitutions in SARS-CoV-2 3CLpro detected in the SCORPIO-SR phase 3 trial.

Ensitrelvir treatment-emergent amino acid substitutions in SARS-CoV-2 3CLpro detected in the SCORPIO-SR phase 3 trial.

Journal: Antiviral research
Published: November 11, 2024

Stability of Respiratory Syncytial Virus in Nasal Aspirate From Patients Infected With RSV.

Stability of Respiratory Syncytial Virus in Nasal Aspirate From Patients Infected With RSV.

Journal: Influenza and other respiratory viruses
Published: July 10, 2024

β-d-N4-hydroxycytidine, a metabolite of molnupiravir, exhibits in vitro antiviral activity against rabies virus.

β-d-N4-hydroxycytidine, a metabolite of molnupiravir, exhibits in vitro antiviral activity against rabies virus.

Journal: Antiviral research
Published: May 12, 2024

Discovery of anti-SARS-CoV-2 S2 protein antibody CV804 with broad-spectrum reactivity with various beta coronaviruses and analysis of its pharmacological properties in vitro and in vivo.

Discovery of anti-SARS-CoV-2 S2 protein antibody CV804 with broad-spectrum reactivity with various beta coronaviruses and analysis of its pharmacological properties in vitro and in vivo.

Journal: PloS one
Published: February 26, 2024

FOUR-WEEK ORAL ADMINISTRATION OF BALOXAVIR MARBOXIL AS AN ANTI-INFLUENZA VIRUS DRUG SHOWS NO TOXICITY IN CHICKENS.

FOUR-WEEK ORAL ADMINISTRATION OF BALOXAVIR MARBOXIL AS AN ANTI-INFLUENZA VIRUS DRUG SHOWS NO TOXICITY IN CHICKENS.

Journal: Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians
Published: January 04, 2024

Prophylactic Treatment with Baloxavir Protects Mice from Lethal Infection with Influenza A and B Viruses.

Prophylactic Treatment with Baloxavir Protects Mice from Lethal Infection with Influenza A and B Viruses.

Journal: Viruses
Published: October 02, 2023

The impact of PA/I38 substitutions and PA polymorphisms on the susceptibility of zoonotic influenza A viruses to baloxavir.

The impact of PA/I38 substitutions and PA polymorphisms on the susceptibility of zoonotic influenza A viruses to baloxavir.

Journal: Archives of virology
Published: August 23, 2023
Showing 1-12 of 45

Last Updated: 09/26/2026